SPIA
PASG icon

Steward Partners Investment Advisory’s Passage Bio PASG Stock Holding History

Steward Partners Investment Advisory’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-51
Closed -$1.02K – 3644
2023
Q4 		$1.02K Hold
51
– – ﹤0.01% 3305
2023
Q3 		$665 Hold
51
– – ﹤0.01% 3234
2023
Q2 		$951 Buy
+51
New +$1.01K ﹤0.01% 3138
2021
Q2 		– Sell
-10
Closed -$3.5K – 7317
2021
Q1 		$3.5K Buy
+10
New +$4.27K ﹤0.01% 3098

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Steward Partners Investment Advisory's PASG Position: Q1 2024 in Review

Steward Partners Investment Advisory sold out of Passage Bio (PASG) in Q1 2024, closing a stake of 51 shares — an estimated $1.02K sold.

Steward Partners Investment Advisory first reported a position in PASG in Q1 2021 and held it in 4 quarters. The position peaked at $3.5K in Q1 2021. 48 funds tracked by Wall St. Rank hold PASG as of Q1 2024.

  • Steward Partners Investment Advisory reported no remaining Passage Bio position as of Q1 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 51 Passage Bio shares in Q1 2024, an estimated $1.02K.
  • Steward Partners Investment Advisory first reported a position in Passage Bio in Q1 2021 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Passage Bio position peaked at $3.5K in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Passage Bio as of Q1 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2024, filed 15 May 2024.